Cerebrolysin

Available in some countries

Description

Cerebrolysin is a mixture of neuropeptides and amino acids derived from porcine brain tissue. It is used to treat various neurological conditions, including stroke and dementia, and is being investigated for CADASIL. It may improve cognitive function and neurological outcomes.

Indications & Therapeutic Use

Stroke, Dementia, CADASIL (investigational)

Linked Diseases:

CADASIL
D046589

Global Availability (4 countries)

CountryAccess RouteRegulatory PathwayLead TimeStatus

Available Through

This drug is available for procurement through the following fulfilment partner.

Fulfilment Partner
Cerebrolysin
Generic NameCerebrolysin
Drug ClassStroke
ManufacturerEVER Neuro Pharma GmbH
Dosage FormsInjection
Medical CodeN06BX
Orphan StatusNo
Cold ChainNot Required
Reg. StatusAvailable in some countries
Clinical TrialNCT00515697
Countries4 countries
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations5 Validated Nodes